Results: 1-25 | 26-50 | 51-55
Results: 1-25/55
5 DISTINCT HUMAN CYTOCHROMES MEDIATE AMITRIPTYLINE N-DEMETHYLATION IN-VITRO - DOMINANCE OF CYP 2C19 AND 3A4
Authors: VENKATAKRISHNAN K GREENBLATT DJ VONMOLTKE LL SCHMIDER J HARMATZ JS SHADER RI
Citation: K. Venkatakrishnan et al., 5 DISTINCT HUMAN CYTOCHROMES MEDIATE AMITRIPTYLINE N-DEMETHYLATION IN-VITRO - DOMINANCE OF CYP 2C19 AND 3A4, Journal of clinical pharmacology, 38(2), 1998, pp. 112-121
AGE-RELATED VARIATIONS IN BASE-LINE VALUES OF NEUROPSYCHIATRIC MEASURES - POTENTIAL CONFOUNDING IN PHARMACOGERIATRIC STUDIES
Authors: SCAVONE JM GREENBLATT DJ HARMATZ JS SHADER RI
Citation: Jm. Scavone et al., AGE-RELATED VARIATIONS IN BASE-LINE VALUES OF NEUROPSYCHIATRIC MEASURES - POTENTIAL CONFOUNDING IN PHARMACOGERIATRIC STUDIES, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 29-29
ALPRAZOLAM HYDROXYLATION BY MOUSE-LIVER MICROSOMES IN-VITRO - THE EFFECT OF AGE AND PHENOBARBITAL INDUCTION
Authors: CHARPENTIER KP VONMOLTKE LL POKU JW HARMATZ JS SHADER RI GREENBLATT DJ
Citation: Kp. Charpentier et al., ALPRAZOLAM HYDROXYLATION BY MOUSE-LIVER MICROSOMES IN-VITRO - THE EFFECT OF AGE AND PHENOBARBITAL INDUCTION, Biopharmaceutics & drug disposition, 18(2), 1997, pp. 139-149
ALPRAZOLAM METABOLISM IN-VITRO - STUDIES OF HUMAN, MONKEY, MOUSE, ANDRAT-LIVER MICROSOMES
Authors: VONMOLTKE LL GREENBLATT DJ HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., ALPRAZOLAM METABOLISM IN-VITRO - STUDIES OF HUMAN, MONKEY, MOUSE, ANDRAT-LIVER MICROSOMES, Pharmacology, 47(4), 1993, pp. 268-276
ALPRAZOLAM PHARMACOKINETICS, METABOLISM, AND PLASMA-LEVELS - CLINICALIMPLICATIONS
Authors: GREENBLATT DJ VONMOLTKE LL HARMATZ JS CIRAULO DA SHADER RI SELLERS EM BALLENGER JC",SCHATZBERG,WEISSMAN,SHEAR
Citation: Dj. Greenblatt et al., ALPRAZOLAM PHARMACOKINETICS, METABOLISM, AND PLASMA-LEVELS - CLINICALIMPLICATIONS, The Journal of clinical psychiatry, 54, 1993, pp. 4-14
ALTERED KINETICS AND DYNAMICS OF TRIAZOLAM IN THE ELDERLY
Authors: GREENBLATT DJ HARMATZ JS WRIGHT CE GOUTHRO T LOCKE J SHADER RI
Citation: Dj. Greenblatt et al., ALTERED KINETICS AND DYNAMICS OF TRIAZOLAM IN THE ELDERLY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 199-199
AN IN-VITRO MODEL TO IDENTIFY AND PREDICT DRUG-INTERACTIONS IN-VIVO
Authors: VONMOLTKE LL GREENBLATT DJ HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., AN IN-VITRO MODEL TO IDENTIFY AND PREDICT DRUG-INTERACTIONS IN-VIVO, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 209-209
APPETITE-SUPPRESSANT DRUGS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - IN-VITRO INHIBITION OF P450-2D6 BY D-FENFLURAMINE AND L-FENFLURAMINE, BUT NOT PHENTERMINE
Authors: VONMOLTKE LL GREENBLATT DJ CIRAULO DA GRASSI JM GRANDA BW DUAN SX HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., APPETITE-SUPPRESSANT DRUGS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - IN-VITRO INHIBITION OF P450-2D6 BY D-FENFLURAMINE AND L-FENFLURAMINE, BUT NOT PHENTERMINE, Journal of clinical psychopharmacology, 18(4), 1998, pp. 338-341
CHARACTERIZATION OF 6 IN-VITRO REACTIONS MEDIATED BY HUMAN CYTOCHROME-P450 - APPLICATION TO THE TESTING OF CYTOCHROME P450-DIRECTED ANTIBODIES
Authors: SCHMIDER J GREENBLATT DJ VONMOLTKE LL HARMATZ JS DUAN SX KARSOV D SHADER RI
Citation: J. Schmider et al., CHARACTERIZATION OF 6 IN-VITRO REACTIONS MEDIATED BY HUMAN CYTOCHROME-P450 - APPLICATION TO THE TESTING OF CYTOCHROME P450-DIRECTED ANTIBODIES, Pharmacology, 52(2), 1996, pp. 125-134
COGNITIVE EFFECTS OF BETA-ADRENERGIC ANTAGONISTS AFTER SINGLE DOSES -PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPRANOLOL, ATENOLOL, LORAZEPAM, AND PLACEBO
Authors: GREENBLATT DJ SCAVONE JM HARMATZ JS ENGELHARDT N SHADER RI
Citation: Dj. Greenblatt et al., COGNITIVE EFFECTS OF BETA-ADRENERGIC ANTAGONISTS AFTER SINGLE DOSES -PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPRANOLOL, ATENOLOL, LORAZEPAM, AND PLACEBO, Clinical pharmacology and therapeutics, 53(5), 1993, pp. 577-584
COMPARATIVE KINETICS AND DYNAMICS OF ZALEPLON, ZOLPIDEM, AND PLACEBO
Authors: GREENBLATT DJ HARMATZ JS VONMOLTKE LL EHRENBERG BL HARREL L CORBETT K COUNIHAN M GRAF JA DARWISH M MERTZANIS P MARTIN PT CEVALLOS WH SHADER RI
Citation: Dj. Greenblatt et al., COMPARATIVE KINETICS AND DYNAMICS OF ZALEPLON, ZOLPIDEM, AND PLACEBO, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 553-561
COMPARATIVE PHARMACODYNAMICS OF INTRAVENOUS ALPRAZOLAM, ADINAZOLAM, DESMETHYLADINAZOLAM, AND PLACEBO
Authors: GREENBLATT DJ EHRENBERG BL HARMATZ JS FLEISHAKER JC CORBETT K HARREL L SHADER RI
Citation: Dj. Greenblatt et al., COMPARATIVE PHARMACODYNAMICS OF INTRAVENOUS ALPRAZOLAM, ADINAZOLAM, DESMETHYLADINAZOLAM, AND PLACEBO, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 79-79
CYTOCHROMES IN PSYCHOPHARMACOLOGY
Authors: VONMOLTKE LL GREENBLATT DJ HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., CYTOCHROMES IN PSYCHOPHARMACOLOGY, Journal of clinical psychopharmacology, 14(1), 1994, pp. 1-4
DIAZEPAM BIOTRANSFORMATION IN-VITRO - SPECIES-DIFFERENCES AND EFFECTSOF INHIBITORS
Authors: PHULL RK GREENBLATT DJ VONMOLTKE LL HARMATZ JS SHADER RI
Citation: Rk. Phull et al., DIAZEPAM BIOTRANSFORMATION IN-VITRO - SPECIES-DIFFERENCES AND EFFECTSOF INHIBITORS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 205-205
DIFFERENTIAL INHIBITION OF DESIPRAMINE HYDROXYLATION IN-VITRO BY THE ENANTIOMERS OF FLUOXETINE
Authors: VONMOLTKE LL GREENBLATT DJ DUAN SX HARMATZ JS ABERG G SHADER RI
Citation: Ll. Vonmoltke et al., DIFFERENTIAL INHIBITION OF DESIPRAMINE HYDROXYLATION IN-VITRO BY THE ENANTIOMERS OF FLUOXETINE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 205-205
DOES ZOLPIDEM HAVE UNIQUE CLINICAL PROPERTIES - A PHARMACODYNAMIC COMPARISON WITH TRIAZOLAM AND PLACEBO
Authors: GREENBLATT DJ HARMATZ JS WRIGHT CE HARREL L SHADER RI
Citation: Dj. Greenblatt et al., DOES ZOLPIDEM HAVE UNIQUE CLINICAL PROPERTIES - A PHARMACODYNAMIC COMPARISON WITH TRIAZOLAM AND PLACEBO, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 78-78
DOSE-DEPENDENT PHARMACOKINETICS AND PSYCHOMOTOR EFFECTS OF CAFFEINE IN HUMANS
Authors: KAPLAN GB GREENBLATT DJ EHRENBERG BL GODDARD JE COTREAU MM HARMATZ JS SHADER RI
Citation: Gb. Kaplan et al., DOSE-DEPENDENT PHARMACOKINETICS AND PSYCHOMOTOR EFFECTS OF CAFFEINE IN HUMANS, Journal of clinical pharmacology, 37(8), 1997, pp. 693-703
DRUG-INTERACTIONS WITH NEWER ANTIDEPRESSANTS - ROLE OF HUMAN CYTOCHROMES P450
Authors: GREENBLATT DJ VONMOLTKE LL HARMATZ JS SHADER RI
Citation: Dj. Greenblatt et al., DRUG-INTERACTIONS WITH NEWER ANTIDEPRESSANTS - ROLE OF HUMAN CYTOCHROMES P450, The Journal of clinical psychiatry, 59, 1998, pp. 19-27
HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO
Authors: VONMOLTKE LL GREENBLATT DJ DUAN SX SCHMIDER J WRIGHT CE HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO, Psychopharmacology, 132(4), 1997, pp. 402-407
HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO
Authors: VONMOLTKE LL GREENBLATT DJ DUAN SX SCHMIDER J HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 48-48
IMPAIRED CLEARANCE OF TRIAZOLAM BY MACROLIDE COADMINISTRATION - IN-VITRO CORRELATES AND CLINICAL CONSEQUENCES
Authors: GREENBLATT DJ VONMOLTKE LL HARMATZ JS WRIGHT CE HARREL L COUNIHAN M GRAF J MERTZANIS P SHADER RI
Citation: Dj. Greenblatt et al., IMPAIRED CLEARANCE OF TRIAZOLAM BY MACROLIDE COADMINISTRATION - IN-VITRO CORRELATES AND CLINICAL CONSEQUENCES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 42-42
INFLUENCE OF ORAL-CONTRACEPTIVE USE AND CIGARETTE-SMOKING, ALONE AND TOGETHER, ON ANTIPYRINE PHARMACOKINETICS
Authors: SCAVONE JM GREENBLATT DJ ABERNETHY DR LUNA BG HARMATZ JS SHADER RI
Citation: Jm. Scavone et al., INFLUENCE OF ORAL-CONTRACEPTIVE USE AND CIGARETTE-SMOKING, ALONE AND TOGETHER, ON ANTIPYRINE PHARMACOKINETICS, Journal of clinical pharmacology, 37(5), 1997, pp. 437-441
INHIBITION OF ALPRAZOLAM AND DESIPRAMINE HYDROXYLATION IN-VITRO BY PAROXETINE AND FLUVOXAMINE - CLINICAL IMPLICATIONS
Authors: VONMOLTKE LL GREENBLATT DJ COURT MH DUAN SX HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., INHIBITION OF ALPRAZOLAM AND DESIPRAMINE HYDROXYLATION IN-VITRO BY PAROXETINE AND FLUVOXAMINE - CLINICAL IMPLICATIONS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 221-221
INHIBITION OF ALPRAZOLAM AND DESIPRAMINE HYDROXYLATION IN-VITRO BY PAROXETINE AND FLUVOXAMINE - COMPARISON WITH OTHER SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTIDEPRESSANTS
Authors: VONMOLTKE LL GREENBLATT DJ COURT MH DUAN SX HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., INHIBITION OF ALPRAZOLAM AND DESIPRAMINE HYDROXYLATION IN-VITRO BY PAROXETINE AND FLUVOXAMINE - COMPARISON WITH OTHER SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTIDEPRESSANTS, Journal of clinical psychopharmacology, 15(2), 1995, pp. 125-131
INHIBITION OF CYTOCHROME-P450 BY NEFAZODONE IN-VITRO - STUDIES OF DEXTROMETHORPHAN O-DEMETHYLATION AND N-DEMETHYLATION
Authors: SCHMIDER J GREENBLATT DJ VONMOLTKE LL HARMATZ JS SHADER RI
Citation: J. Schmider et al., INHIBITION OF CYTOCHROME-P450 BY NEFAZODONE IN-VITRO - STUDIES OF DEXTROMETHORPHAN O-DEMETHYLATION AND N-DEMETHYLATION, British journal of clinical pharmacology, 41(4), 1996, pp. 339-343
Risultati: 1-25 | 26-50 | 51-55